Patient global assessment in psoriatic arthritis: A multicenter GRAPPA and OMERACT study

Alberto Cauli, Dafna D. Gladman, Alessandro Mathieu, Ignazio Olivieri, Giovanni Porru, Paul P. Tak, Claudia Sardu, Ilona Ujfalussy, Raffaele Scarpa, Antonio Marchesoni, William J. Taylor, Antonio Spadaro, Jose L. Fernàndez-Sueiro, Carlo Salvarani, Joachim R. Kalden, Ennio Lubrano, Sueli Carneiro, Francesca Desiati, John A. Flynn, Salvatore D'AngeloAlessandra Vacca, Arno W R Van Kuijk, Maria Grazia Catanoso, Mathias Gruenke, Rosario Peluso, Wendy J. Parsons, Nicola Ferrara, Paolo Contu, Philip S. Helliwell, Philip J. Mease

Research output: Contribution to journalArticle

Abstract

Objective. During OMERACT 8, delegates selected patient global assessment (PGA) of disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). This study assessed the reliability of the PGA, measured by means of 0-100 mm visual analog scale (VAS), and the additional utility of separate VAS scales for joints (PJA) and skin (PSA). Methods. In total, 319 consecutive patients with PsA (186 men, 133 women, mean age 51 ± 13 yrs) were enrolled. PGA, PJA, and PSA were administered at enrolment (W0) and after 1 week (W1). Detailed clinical data, including ACR joint count, Psoriasis Area and Severity Index (PASI), and Hospital Anxiety and Depression Scale, were recorded. Results. Comparison of W0 and W1 scores showed no significant variations (intraclass correlation coefficients for PGA 0.87, PJA 0.86, PSA 0.78), demonstrating the reliability of the instrument. PGA scores were not influenced by patient anxiety or depression, but were dependent on PJA and PSA (p = 0.00001). PJA was dependent on the number of swollen and tender joints (p <0.00001). PSA scores were influenced by the extent of skin psoriasis and by hand skin involvement (p = 0.00001). Joint and skin disease were found not to correlate in terms of disease activity as evidenced by the swollen joint count compared to PASI (r = 0.11) and by the PJA compared to PSA (r = 0.38). Conclusion. PGA assessed by means of VAS is a reliable tool related to joint and skin disease activity. Because joint and skin disease often diverge it is suggested that in some circumstances both PJA and PSA are also assessed. The Journal of Rheumatology

Original languageEnglish (US)
Pages (from-to)898-903
Number of pages6
JournalJournal of Rheumatology
Volume38
Issue number5
DOIs
StatePublished - May 2011

Fingerprint

Psoriatic Arthritis
Joint Diseases
Joints
Visual Analog Scale
Psoriasis
Skin Diseases
Skin
Anxiety
Depression
Rheumatology
Randomized Controlled Trials
Hand

Keywords

  • Assessment measures
  • Domains
  • Instruments
  • Patient global assessment
  • Psoriatic arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Cauli, A., Gladman, D. D., Mathieu, A., Olivieri, I., Porru, G., Tak, P. P., ... Mease, P. J. (2011). Patient global assessment in psoriatic arthritis: A multicenter GRAPPA and OMERACT study. Journal of Rheumatology, 38(5), 898-903. https://doi.org/10.3899/jrheum.100857

Patient global assessment in psoriatic arthritis : A multicenter GRAPPA and OMERACT study. / Cauli, Alberto; Gladman, Dafna D.; Mathieu, Alessandro; Olivieri, Ignazio; Porru, Giovanni; Tak, Paul P.; Sardu, Claudia; Ujfalussy, Ilona; Scarpa, Raffaele; Marchesoni, Antonio; Taylor, William J.; Spadaro, Antonio; Fernàndez-Sueiro, Jose L.; Salvarani, Carlo; Kalden, Joachim R.; Lubrano, Ennio; Carneiro, Sueli; Desiati, Francesca; Flynn, John A.; D'Angelo, Salvatore; Vacca, Alessandra; Van Kuijk, Arno W R; Catanoso, Maria Grazia; Gruenke, Mathias; Peluso, Rosario; Parsons, Wendy J.; Ferrara, Nicola; Contu, Paolo; Helliwell, Philip S.; Mease, Philip J.

In: Journal of Rheumatology, Vol. 38, No. 5, 05.2011, p. 898-903.

Research output: Contribution to journalArticle

Cauli, A, Gladman, DD, Mathieu, A, Olivieri, I, Porru, G, Tak, PP, Sardu, C, Ujfalussy, I, Scarpa, R, Marchesoni, A, Taylor, WJ, Spadaro, A, Fernàndez-Sueiro, JL, Salvarani, C, Kalden, JR, Lubrano, E, Carneiro, S, Desiati, F, Flynn, JA, D'Angelo, S, Vacca, A, Van Kuijk, AWR, Catanoso, MG, Gruenke, M, Peluso, R, Parsons, WJ, Ferrara, N, Contu, P, Helliwell, PS & Mease, PJ 2011, 'Patient global assessment in psoriatic arthritis: A multicenter GRAPPA and OMERACT study', Journal of Rheumatology, vol. 38, no. 5, pp. 898-903. https://doi.org/10.3899/jrheum.100857
Cauli, Alberto ; Gladman, Dafna D. ; Mathieu, Alessandro ; Olivieri, Ignazio ; Porru, Giovanni ; Tak, Paul P. ; Sardu, Claudia ; Ujfalussy, Ilona ; Scarpa, Raffaele ; Marchesoni, Antonio ; Taylor, William J. ; Spadaro, Antonio ; Fernàndez-Sueiro, Jose L. ; Salvarani, Carlo ; Kalden, Joachim R. ; Lubrano, Ennio ; Carneiro, Sueli ; Desiati, Francesca ; Flynn, John A. ; D'Angelo, Salvatore ; Vacca, Alessandra ; Van Kuijk, Arno W R ; Catanoso, Maria Grazia ; Gruenke, Mathias ; Peluso, Rosario ; Parsons, Wendy J. ; Ferrara, Nicola ; Contu, Paolo ; Helliwell, Philip S. ; Mease, Philip J. / Patient global assessment in psoriatic arthritis : A multicenter GRAPPA and OMERACT study. In: Journal of Rheumatology. 2011 ; Vol. 38, No. 5. pp. 898-903.
@article{5e8af39ee95b4ccab35b7e00bc3a4287,
title = "Patient global assessment in psoriatic arthritis: A multicenter GRAPPA and OMERACT study",
abstract = "Objective. During OMERACT 8, delegates selected patient global assessment (PGA) of disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). This study assessed the reliability of the PGA, measured by means of 0-100 mm visual analog scale (VAS), and the additional utility of separate VAS scales for joints (PJA) and skin (PSA). Methods. In total, 319 consecutive patients with PsA (186 men, 133 women, mean age 51 ± 13 yrs) were enrolled. PGA, PJA, and PSA were administered at enrolment (W0) and after 1 week (W1). Detailed clinical data, including ACR joint count, Psoriasis Area and Severity Index (PASI), and Hospital Anxiety and Depression Scale, were recorded. Results. Comparison of W0 and W1 scores showed no significant variations (intraclass correlation coefficients for PGA 0.87, PJA 0.86, PSA 0.78), demonstrating the reliability of the instrument. PGA scores were not influenced by patient anxiety or depression, but were dependent on PJA and PSA (p = 0.00001). PJA was dependent on the number of swollen and tender joints (p <0.00001). PSA scores were influenced by the extent of skin psoriasis and by hand skin involvement (p = 0.00001). Joint and skin disease were found not to correlate in terms of disease activity as evidenced by the swollen joint count compared to PASI (r = 0.11) and by the PJA compared to PSA (r = 0.38). Conclusion. PGA assessed by means of VAS is a reliable tool related to joint and skin disease activity. Because joint and skin disease often diverge it is suggested that in some circumstances both PJA and PSA are also assessed. The Journal of Rheumatology",
keywords = "Assessment measures, Domains, Instruments, Patient global assessment, Psoriatic arthritis",
author = "Alberto Cauli and Gladman, {Dafna D.} and Alessandro Mathieu and Ignazio Olivieri and Giovanni Porru and Tak, {Paul P.} and Claudia Sardu and Ilona Ujfalussy and Raffaele Scarpa and Antonio Marchesoni and Taylor, {William J.} and Antonio Spadaro and Fern{\`a}ndez-Sueiro, {Jose L.} and Carlo Salvarani and Kalden, {Joachim R.} and Ennio Lubrano and Sueli Carneiro and Francesca Desiati and Flynn, {John A.} and Salvatore D'Angelo and Alessandra Vacca and {Van Kuijk}, {Arno W R} and Catanoso, {Maria Grazia} and Mathias Gruenke and Rosario Peluso and Parsons, {Wendy J.} and Nicola Ferrara and Paolo Contu and Helliwell, {Philip S.} and Mease, {Philip J.}",
year = "2011",
month = "5",
doi = "10.3899/jrheum.100857",
language = "English (US)",
volume = "38",
pages = "898--903",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "5",

}

TY - JOUR

T1 - Patient global assessment in psoriatic arthritis

T2 - A multicenter GRAPPA and OMERACT study

AU - Cauli, Alberto

AU - Gladman, Dafna D.

AU - Mathieu, Alessandro

AU - Olivieri, Ignazio

AU - Porru, Giovanni

AU - Tak, Paul P.

AU - Sardu, Claudia

AU - Ujfalussy, Ilona

AU - Scarpa, Raffaele

AU - Marchesoni, Antonio

AU - Taylor, William J.

AU - Spadaro, Antonio

AU - Fernàndez-Sueiro, Jose L.

AU - Salvarani, Carlo

AU - Kalden, Joachim R.

AU - Lubrano, Ennio

AU - Carneiro, Sueli

AU - Desiati, Francesca

AU - Flynn, John A.

AU - D'Angelo, Salvatore

AU - Vacca, Alessandra

AU - Van Kuijk, Arno W R

AU - Catanoso, Maria Grazia

AU - Gruenke, Mathias

AU - Peluso, Rosario

AU - Parsons, Wendy J.

AU - Ferrara, Nicola

AU - Contu, Paolo

AU - Helliwell, Philip S.

AU - Mease, Philip J.

PY - 2011/5

Y1 - 2011/5

N2 - Objective. During OMERACT 8, delegates selected patient global assessment (PGA) of disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). This study assessed the reliability of the PGA, measured by means of 0-100 mm visual analog scale (VAS), and the additional utility of separate VAS scales for joints (PJA) and skin (PSA). Methods. In total, 319 consecutive patients with PsA (186 men, 133 women, mean age 51 ± 13 yrs) were enrolled. PGA, PJA, and PSA were administered at enrolment (W0) and after 1 week (W1). Detailed clinical data, including ACR joint count, Psoriasis Area and Severity Index (PASI), and Hospital Anxiety and Depression Scale, were recorded. Results. Comparison of W0 and W1 scores showed no significant variations (intraclass correlation coefficients for PGA 0.87, PJA 0.86, PSA 0.78), demonstrating the reliability of the instrument. PGA scores were not influenced by patient anxiety or depression, but were dependent on PJA and PSA (p = 0.00001). PJA was dependent on the number of swollen and tender joints (p <0.00001). PSA scores were influenced by the extent of skin psoriasis and by hand skin involvement (p = 0.00001). Joint and skin disease were found not to correlate in terms of disease activity as evidenced by the swollen joint count compared to PASI (r = 0.11) and by the PJA compared to PSA (r = 0.38). Conclusion. PGA assessed by means of VAS is a reliable tool related to joint and skin disease activity. Because joint and skin disease often diverge it is suggested that in some circumstances both PJA and PSA are also assessed. The Journal of Rheumatology

AB - Objective. During OMERACT 8, delegates selected patient global assessment (PGA) of disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). This study assessed the reliability of the PGA, measured by means of 0-100 mm visual analog scale (VAS), and the additional utility of separate VAS scales for joints (PJA) and skin (PSA). Methods. In total, 319 consecutive patients with PsA (186 men, 133 women, mean age 51 ± 13 yrs) were enrolled. PGA, PJA, and PSA were administered at enrolment (W0) and after 1 week (W1). Detailed clinical data, including ACR joint count, Psoriasis Area and Severity Index (PASI), and Hospital Anxiety and Depression Scale, were recorded. Results. Comparison of W0 and W1 scores showed no significant variations (intraclass correlation coefficients for PGA 0.87, PJA 0.86, PSA 0.78), demonstrating the reliability of the instrument. PGA scores were not influenced by patient anxiety or depression, but were dependent on PJA and PSA (p = 0.00001). PJA was dependent on the number of swollen and tender joints (p <0.00001). PSA scores were influenced by the extent of skin psoriasis and by hand skin involvement (p = 0.00001). Joint and skin disease were found not to correlate in terms of disease activity as evidenced by the swollen joint count compared to PASI (r = 0.11) and by the PJA compared to PSA (r = 0.38). Conclusion. PGA assessed by means of VAS is a reliable tool related to joint and skin disease activity. Because joint and skin disease often diverge it is suggested that in some circumstances both PJA and PSA are also assessed. The Journal of Rheumatology

KW - Assessment measures

KW - Domains

KW - Instruments

KW - Patient global assessment

KW - Psoriatic arthritis

UR - http://www.scopus.com/inward/record.url?scp=79955568037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955568037&partnerID=8YFLogxK

U2 - 10.3899/jrheum.100857

DO - 10.3899/jrheum.100857

M3 - Article

C2 - 21324965

AN - SCOPUS:79955568037

VL - 38

SP - 898

EP - 903

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 5

ER -